NCT05278325

Brief Summary

The purpose of the study is to improve treatment for newly referred patients with migraine and tension-type headache to the Danish Headache Center. All patients will recieve an electronic questionnaire just before the first visit concerning their current and previous history of headache and headache treatment. Half of them will enter a special telephone-intervention (TeII) program with two planned phone-calls after 8 and 16 weeks from first visit. The other half of patients will follow the normal follow-up program. All patients will be seen by a headache specialist after 6 months and will be asked to fill in a follow-up electronic questionnaire.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
187

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2020

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2021

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 5, 2021

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

February 23, 2022

Completed
19 days until next milestone

First Posted

Study publicly available on registry

March 14, 2022

Completed
Last Updated

March 14, 2022

Status Verified

March 1, 2022

Enrollment Period

11 months

First QC Date

February 23, 2022

Last Update Submit

March 3, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in preventive headache medication

    Difference in number of patients with change in preventive headache medication in the two groups

    From baseline to six months

  • Change in acute headache medication

    Difference in number of patients with change in acute headache medication in the two groups

    From baseline to six months

Secondary Outcomes (6)

  • Change in headache frequency

    From baseline to six months

  • Change in migraine frequency

    From baseline to six months

  • Change in Headache Under response to Treatment (HURT-8) score

    From baseline to six months

  • Change in Insomnia Severity Index (ISI) score

    From baseline to six months

  • Change in Hospitality Anxiety Depression Scale (HADS) score

    From baseline to six months

  • +1 more secondary outcomes

Study Arms (2)

Telephone Intervention

EXPERIMENTAL

Two planned phone call by health care professionals after 8 and 16 weeks adjusting acute and preventive treatment

Other: Telephone intervention

Business as usual

NO INTERVENTION

No planned phone calls

Interventions

Two planned phone call between clinical controls

Telephone Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Migraine and/or tension-type headache

You may not qualify if:

  • Other headache diagnoses, including cluster headache, medication overuse-headache, other secondary headaches, trigeminal neuralgia.
  • Included in clinical trials at the DHC.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Danish Headache Center

Glostrup Municipality, Copenhagen, 2600, Denmark

Location

MeSH Terms

Conditions

Migraine DisordersTension-Type Headache

Condition Hierarchy (Ancestors)

Headache Disorders, PrimaryHeadache DisordersBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Henrik W Schytz, Ass Prof

    Rigshospitalet-Glostrup, Afdeling for Hjerne- og Nervesygdomme

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD, MD

Study Record Dates

First Submitted

February 23, 2022

First Posted

March 14, 2022

Study Start

May 1, 2020

Primary Completion

April 1, 2021

Study Completion

October 5, 2021

Last Updated

March 14, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will not share

Locations